MEDP - Medpace Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
-1.05 (-1.50%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close70.22
Bid0.00 x 900
Ask0.00 x 1000
Day's Range68.78 - 70.23
52 Week Range31.75 - 70.78
Avg. Volume732,285
Market Cap2.449B
Beta (3Y Monthly)1.77
PE Ratio (TTM)41.92
EPS (TTM)1.65
Earnings DateOct 29, 2018 - Nov 2, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est59.40
Trade prices are not sourced from all markets
  • Medpace (MEDP) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks4 days ago

    Medpace (MEDP) Reports Next Week: Wall Street Expects Earnings Growth

    Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Anatomy Of Sell Decisions In Medpace Stock
    Investor's Business Daily13 days ago

    Anatomy Of Sell Decisions In Medpace Stock

    Deciding when to sell stocks is a struggle. Even when a stock is doing well. Sell too early and you miss gains. Sell too late and you miss profits.

  • Markit14 days ago

    See what the IHS Markit Score report has to say about Medpace Holdings Inc.

    Medpace Holdings Inc NASDAQ/NGS:MEDPView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NegativeShort interest is moderately high for MEDP with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding MEDP totaled $3.80 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire14 days ago

    Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on February 25, 2019

    Medpace Holdings, Inc. today announced that it will report its fourth quarter and fiscal year 2018 financial results after the market close on Monday, February 25, 2019.

  • GuruFocus.com16 days ago

    Medpace Holdings Inc (MEDP) President & CEO August J. Troendle Sold $6.8 million of Shares

    President & CEO of Medpace Holdings Inc (NASDAQ:MEDP) August J. Troendle sold 103,013 shares of MEDP on 02/04/2019 at an average price of $65.72 a share.

  • GlobeNewswire17 days ago

    Analysis: Positioning to Benefit within Xylem, Integer, Medpace, Comstock Resources, Marriott Vacations Worldwide, and Big 5 Sporting Goods — Research Highlights Growth, Revenue, and Consolidated Results

    NEW YORK, Feb. 05, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • IBD Stock Of The Day Surges Higher On 4-Day Sprint For Medical Stocks
    Investor's Business Daily20 days ago

    IBD Stock Of The Day Surges Higher On 4-Day Sprint For Medical Stocks

    Shares of IBD Stock Of The Day Medpace Holdings surged higher Friday amid a four-day buying spree for medical-research stocks. Medpace stock is on the IBD 50 and rose more than 2%.

  • GuruFocus.com21 days ago

    Medpace Holdings Inc (MEDP) President & CEO August J. Troendle Sold $11 million of Shares

    President & CEO of Medpace Holdings Inc (NASDAQ:MEDP) August J. Troendle sold 172,311 shares of MEDP on 01/31/2019 at an average price of $63.59 a share.

  • 10 Triple-A Stocks to Buy in February
    InvestorPlace27 days ago

    10 Triple-A Stocks to Buy in February

    They say it's a bullish sign when the markets climb a wall of worry. That means, while things look grim -- government shutdown, unimpressive earnings, slow trade talks with China, Brexit confusion, saber-rattling in oil-rich Venezuela -- the market keeps on chugging upwards. Something good must be happening just beyond the horizon. Remember, the market is always looking six months out, so whatever is happening this quarter was priced in more or less last year. It's likely the market sees lower interest rates that will revive real estate and housing sectors, solid consumer spending that will help retail and a happy ending to the trade war with China. InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 5 of the Best Stocks to Buy and Hold for the Long Term With that in mind, I thought it might be a good idea to feature 10 triple-A stocks to buy in February from my Portfolio Grader. All took high marks in sales, earnings and quant categories, the latter meaning there's gathering interest in the shares. Source: Via Amazon ### Amazon (AMZN) Amazon (NASDAQ:AMZN) is an easy one to start with. After a sluggish 2018 -- the stock only rose a mere 28%, when its three-year average is around 58% annually -- it is already moving quickly to get back on its uniquely powerful growth pace. And as long as consumers keep spending, AMZN will keep racking up the gains. AMZN is moving into the beauty sector now, launching its "find" brand in the UK, with move regions to follow. Its focused on beauty supplies at the $20-and-under price level, but if its popular, you can be sure AMZN will expand up the price chain. The one tough spot is its move into the Indian market. Having already sunk at least $5 billion developing the market, new laws may make its headway more difficult. But it still has plenty of opportunities beyond India. Source: Shutterstock ### ConocoPhillips (COP) ConocoPhillips (NYSE:COP) is one of the oldest oil and gas exploration and production (E&P) firms in the U.S. And it's also one of the biggest E&Ps in the world, having operations around the globe. It even has an LNG (liquified natural gas) export port in Australia to ship natural gas to Asia, where margins are the highest in the world. COP is a story of economies. When economies are expanding, demand for energy rises. When economies contract, energy demand slacks. In either case, the first sector to feel the move is E&Ps, since their focus is on getting it out of the ground or finding new places to explore. * 10 Hot Stocks to Buy Right Now Because of its size, COP is a great choice in this sector right now. It's big enough to absorb some of the short-term volatility but it will still keep some of the leverage when demand increases. It's a solid value right now. Source: Shutterstock ### Veeva Systems (VEEV) Veeva Systems (NYSE:VEEV) is up more than 20% in January and up nearly 83% in the past 12 months. This stock was completely unaffected by last year's tech tumult. Why? Because it has built a unique niche where it is the leading firm -- it makes cloud-based software solutions for life sciences companies. Life sciences is a unique animal when it comes to the demand on a cloud-based system. There all sorts of regulations and protocols about information sharing and documentation. Plus, all the research aspects and then the marketing side of things make for a very complex system. Veeva is a leader in this sector. And given the generally conservative nature of doctors and research scientists, going with a proven name is a big deal. And it shows in VEEV stock's success. Source: Shutterstock ### Abiomed (ABMD) Abiomed (NASDAQ:ABMD) is a medical device company that has carved out its own unique and important niche in the sector. It makes artificial heart pumps -- the smallest in the world. And it makes equipment that helps monitor and manage diagnostics on heart function with its Impella-brand pumps. This is one of those devices that are valued by all parties -- surgeons, patients, hospitals and insurers. It means less invasive surgeries, which means less down time and risk of infection, which means less costs. * 7 Stupidly Cheap Stocks to Buy Now As industrialized world, where quality healthcare is reasonably accessible, ages, these kinds of solutions become much more in demand. And given its reputation in this sector, ABMD is at the top of the list when healthcare professionals and insurers are ordering equipment. Source: Shutterstock ### Medpace Holdings (MEDP) Medpace Holdings (NASDAQ:MEDP) is one of a new breed of companies that specializes in partnering with pharmaceutical and healthcare equipment companies to work through clinical trials. These types of companies are also known as clinical research organizations (CROs). With clinical trials for pharmaceuticals running about $2 billion per drug, it's important that pharmas are doing it right the first time. Traditionally, big pharmas would take a drug from its own R&D, develop it, get it through trials and then market it. Nowadays, big pharma can buy a promising drug (or drug company) or partner with another firm, assess its potential, contract out the trials and then market it. MEDP takes that trial piece. This is a very promising sector and MEDP is one of the leaders. It has had a solid move in January and that should continue for a long time to come. Source: Shutterstock ### Trade Desk (TTD) Trade Desk (NYSE:TTD) is a new advertising company that is making a big splash. It basically has built a digital advertising platform that allows marketers to create personalized marketing experiences across platforms and channels. Essentially, it allows marketers to buy space on mobile, social and desktop, and develop targeted audiences with targeted messages and video. It's the next wave in advertising and is a trail that was blazed by big firms like Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) and Amazon and is now finding its way to the mainstream. * 7 Dark Horse Stocks You Really Need to Look at for 2019 The stock is up a stunning 185% in the past 12 months, and over 20% in January alone. The one caveat here is its trailing price-to-earnings ratio is around 100, which given its growth seems fairly reasonable. But advertising revenue is tricky and can vary. If it varies to the downside, volatility will ensue. Be patient. Source: Shutterstock ### Ritchie Brothers Auctioneers (RBA) Ritchie Brothers Auctioneers (NYSE:RBA) is a unique company that is in an ideal position in the current market. It is one of the leading auction houses for industrial and agricultural equipment in North America. It has onsite auctions and online auctions as well as brokerage services. If you're a construction company that needs more equipment but aren't sure if buying new is a good move right now, RBA is a good source. And the same can be said of farmers who are looking to offload some equipment or pick up something without spending big on a new rig. It's not growing like a tech stock, but this is a solid business that has been around since 1958, so it knows its customers and respects its shareholders. Source: Shutterstock ### Sabra Healthcare REIT (SBRA) Sabra Healthcare REIT (NASDAQ:SBRA) has been on a roll in 2019, up more than 20% so far. That's impressive for a REIT (real estate investment trust) that specializes in properties for healthcare-related companies. Actually, that's pretty impressive for most REITs -- or most stocks for that matter. A REIT is structured so that shareholders are "paid" out of the company's net profits, like they're an owner. REITs usually do this in the form of a dividend. SBRA is delivering a 9% dividend at this point, and that's after its big run. * 7 Retail Stocks to Buy for the Rise of Menswear This is one of the top growth sectors in the REIT universe at this point. And it has a long way to go before it starts to slow down. If you're looking for a long-term total return play, this is it. Source: Shutterstock ### Inogen (INGN) Inogen (NASDAQ:INGN) is a healthcare equipment company that has been very good at establishing itself in a long-term trend with a specialized product in a growing sector. INGN makes portable oxygen concentrators for long-term use. Traditionally, people that had respiratory issues and needed supplemental oxygen had to wheel around tanks of oxygen. The tanks are heavy, so they needed a small cart to wheeled around. The whole process is difficult and cumbersome, especially for those it was trying to help. INGN products essentially take the oxygen from the air and concentrate it, so there's no need for the tanks. Their products can be carried on your shoulder. And units for the house are also less ungainly. What's more, there are no more oxygen tanks -- full or empty -- laying around the house and getting delivered. Source: Shutterstock ### Rexford Industrial Realty (REXR) Rexford Industrial Realty (NYSE:REXR) specializes in industrial properties in Southern California. Bear in mind that the two top seaports in the U.S. are the Los Angeles seaport and the Long Beach seaport. That means enormous amounts of goods are coming and going out of these ports and need to be stowed somewhere until they're ready to be shipped or distributed. REXR has only been in business for about six years, so it's still in its acquisition phase. While the China-U.S. trade war may slow it business a bit, it's also an opportunity to buy up properties from companies that are having a tough time operating their properties. * 5 of the Best Stocks to Buy and Hold for the Long Term It's delivering a 1.9% dividend right now, which isn't a lot for a REIT, but REXR stock is up 12% this month. More positive movement on trade talks will help lift it even more. Louis Navellier is a renowned growth investor. He is the editor of four investing newsletters: Growth Investor, Breakthrough Stocks, Accelerated Profits and Platinum Growth. His most popular service, Growth Investor, has a track record of beating the market 3:1 over the last 14 years. He uses a combination of quantitative and fundamental analysis to identify market-beating stocks. Mr. Navellier has made his proven formula accessible to investors via his free, online stock rating tool, Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Semiconductor Stocks to Buy Now * 10 of the Best Stocks to Invest In for February * 5 Top Stocks for a FOMO Rally Compare Brokers The post 10 Triple-A Stocks to Buy in February appeared first on InvestorPlace.

  • What Should You Know About Medpace Holdings, Inc.’s (NASDAQ:MEDP) Future?
    Simply Wall St.last month

    What Should You Know About Medpace Holdings, Inc.’s (NASDAQ:MEDP) Future?

    In September 2018, Medpace Holdings, Inc. (NASDAQ:MEDP) announced its earnings update. Overall, analysts seem cautiously optimistic, as upcoming earnings growth is expected to be 50% next year, similar to the Read More...

  • Look Before You Leap: Using Test Trades In A Rally
    Investor's Business Daily2 months ago

    Look Before You Leap: Using Test Trades In A Rally

    It is still too early to tell whether the stock market correction is over. Test trades with a half position on swing trades are useful in that regard.

  • What's in Store for Teladoc in 2019, After a Strong 2018?
    Zacks2 months ago

    What's in Store for Teladoc in 2019, After a Strong 2018?

    Teladoc (TDOC) should continue to gain from increasing demand for its services and global expansion.

  • Cigna Poised for Growth in 2019 on Express Scripts Buyout
    Zacks2 months ago

    Cigna Poised for Growth in 2019 on Express Scripts Buyout

    The purchase of Express Scripts by Cigna (CI) has diversified its business, which should fuel long-term growth.

  • Why This IBD Stock Of The Day 'Continues To Push For New Highs'
    Investor's Business Daily2 months ago

    Why This IBD Stock Of The Day 'Continues To Push For New Highs'

    Medpace Holdings is the IBD Stock Of The Day as shares consolidate and its relative strength line approaches recent highs. Medpace Holdings stock is expected to break out at 65.19.

  • MEDP or HQY: Which Is the Better Value Stock Right Now?
    Zacks2 months ago

    MEDP or HQY: Which Is the Better Value Stock Right Now?

    MEDP vs. HQY: Which Stock Is the Better Value Option?

  • These Cincinnati stocks benefited most from market’s massive rally
    American City Business Journals2 months ago

    These Cincinnati stocks benefited most from market’s massive rally

    Following their worst-ever Christmas Eve on Monday, stocks staged a comeback on Wednesday with the Dow posting its largest daily point gain ever, and Cincinnati stocks weren’t left out of the boost.

  • Cincinnati health care firm joins S&P index
    American City Business Journals2 months ago

    Cincinnati health care firm joins S&P index

    Medpace Holdings Inc. will become part of a Standard & Poor’s stock market index before the open of trading on Jan. 2. Madisonville-based Medpace (Nasdaq: MEDP), which conducts clinical trials for companies worldwide that want to bring new drugs and medical devices to market, will be added to the S&P SmallCap 600’s health care sector under the Life Sciences Tools & Services sub-industry index.

  • The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
    Zacks2 months ago

    The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

    The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

  • Zacks2 months ago

    5 Healthcare Bets to Stay in Investors Good Books Next Year

    Based on a few key factors, we zero in on five stocks that show promise to retain the bull run in 2019.

  • Hedge Funds Are Crazy About Medpace Holdings, Inc. (MEDP)
    Insider Monkey2 months ago

    Hedge Funds Are Crazy About Medpace Holdings, Inc. (MEDP)

    Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The one and a half month time period since the end of the […]

  • Teladoc (TDOC) Surges 64% in a Year: Can the Rally Continue?
    Zacks2 months ago

    Teladoc (TDOC) Surges 64% in a Year: Can the Rally Continue?

    Teladoc (TDOC) is poised to grow on accelerating demand for its telehealth services.